Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy 89bio stock | $17.39

Learn how to easily invest in 89bio stock.

89bio Inc is a biotechnology business based in the US. 89bio shares (ETNB) are listed on the NASDAQ and all prices are listed in US Dollars. 89bio employs 26 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in 89bio

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ETNB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

89bio stock price (NASDAQ: ETNB)

Use our graph to track the performance of ETNB stocks over time.

89bio shares at a glance

Information last updated 2021-10-16.
Latest market close$17.39
52-week range$14.70 - $28.28
50-day moving average $19.45
200-day moving average $20.19
Wall St. target price$52.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.27

Buy 89bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy 89bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

89bio price performance over time

Historical closes compared with the close of $17.39 from 2021-10-20

1 week (2021-10-14) -3.17%
1 month (2021-09-21) -14.25%
3 months (2021-07-21) -0.57%
6 months (2021-04-21) -37.89%
1 year (2020-10-21) -26.56%
2 years (2019-10-17) N/A
3 years (2018-10-17) N/A
5 years (2016-10-17) N/A

89bio financials

Gross profit TTM $0
Return on assets TTM -30.14%
Return on equity TTM -51.71%
Profit margin 0%
Book value $8.60
Market capitalisation $363 million

TTM: trailing 12 months

Shorting 89bio shares

There are currently 936,055 89bio shares held short by investors – that's known as 89bio's "short interest". This figure is 0.3% down from 938,858 last month.

There are a few different ways that this level of interest in shorting 89bio shares can be evaluated.

89bio's "short interest ratio" (SIR)

89bio's "short interest ratio" (SIR) is the quantity of 89bio shares currently shorted divided by the average quantity of 89bio shares traded daily (recently around 87400.093370682). 89bio's SIR currently stands at 10.71. In other words for every 100,000 89bio shares traded daily on the market, roughly 10710 shares are currently held short.

However 89bio's short interest can also be evaluated against the total number of 89bio shares, or, against the total number of tradable 89bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case 89bio's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 89bio shares in existence, roughly 50 shares are currently held short) or 0.1113% of the tradable shares (for every 100,000 tradable 89bio shares, roughly 111 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against 89bio.

Find out more about how you can short 89bio stock.

89bio share dividends

We're not expecting 89bio to pay a dividend over the next 12 months.

89bio overview

89bio, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop BIO89-100 for the treatment of severe hypertriglyceridemia. 89bio, Inc. was founded in 2018 and is based in San Francisco, California. .

Frequently asked questions

What percentage of 89bio is owned by insiders or institutions?
Currently 1.13% of 89bio shares are held by insiders and 99.253% by institutions.
How many people work for 89bio?
Latest data suggests 26 work at 89bio.
When does the fiscal year end for 89bio?
89bio's fiscal year ends in December.
Where is 89bio based?
89bio's address is: 142 Sansome Street, San Francisco, CA, United States, 94104
What is 89bio's ISIN number?
89bio's international securities identification number is: US2825591033
What is 89bio's CUSIP number?
89bio's Committee on Uniform Securities Identification Procedures number is: 282559103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site